share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰制药 | 144:拟议出售证券
美股sec公告 ·  06/12 10:01
Moomoo AI 已提取核心信息
Vertex Pharmaceuticals Inc. officer, Atkinson Edward Morrow III, is set to sell 7,288 shares of common stock on 06/12/2024, with an aggregate market value of approximately $3,483,664. The shares were acquired on 06/10/2024 through restricted stock vesting as part of compensation from the issuer. This transaction follows a period where no securities were sold by Morrow in the past three months, as per the latest filings.
Vertex Pharmaceuticals Inc. officer, Atkinson Edward Morrow III, is set to sell 7,288 shares of common stock on 06/12/2024, with an aggregate market value of approximately $3,483,664. The shares were acquired on 06/10/2024 through restricted stock vesting as part of compensation from the issuer. This transaction follows a period where no securities were sold by Morrow in the past three months, as per the latest filings.
2024年06月12日,Vertex Pharmaceuticals Inc.高管Atkinson Edward Morrow III将以约3,483,664美元的市值出售7,288股普通股。这些股票是作为股票限制性解除计划的一部分,是作为发行人补偿的一部分获取的,于2024年06月10日取得。根据最新披露的文件,此次交易发生在Morrow未在过去三个月内出售过任何证券的时期之后。
2024年06月12日,Vertex Pharmaceuticals Inc.高管Atkinson Edward Morrow III将以约3,483,664美元的市值出售7,288股普通股。这些股票是作为股票限制性解除计划的一部分,是作为发行人补偿的一部分获取的,于2024年06月10日取得。根据最新披露的文件,此次交易发生在Morrow未在过去三个月内出售过任何证券的时期之后。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息